Pharmaceutical compositions comprising phenylaminopyrimidine derivative
An oral pharmaceutical formulation containing an effective amount of NRC-AN-019 including its pharmaceutically acceptable salts and polymorphs thereof, by dispersing in a polymer system in a final state of subdivision to enhance oral bioavailability. It also relates to processes for the preparation...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; heb |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Kali Satya Bhujanga Rao ADIBHATLA Durga Maheswari PARVATANENI Venkaiah Chowdary NANNAPANENI Mitrabhanu MOHANTY Venkata Satyanarayana APPADWEDULA |
| description | An oral pharmaceutical formulation containing an effective amount of NRC-AN-019 including its pharmaceutically acceptable salts and polymorphs thereof, by dispersing in a polymer system in a final state of subdivision to enhance oral bioavailability. It also relates to processes for the preparation of such compositions and using those compositions for the treatment of Chronic Myeloid Leukemia and other tumors such as head and neck cancer, prostate cancer and the like. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_IL260085B</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>IL260085B</sourcerecordid><originalsourceid>FETCH-epo_espacenet_IL260085B3</originalsourceid><addsrcrecordid>eNrjZHAPyEgsyk1MTi0tyUxOzFFIzs8tyC_OLMnMzysGc4oyizPz0hUKMlLzKnMSczPz8gsqizJzM1My81IVUlKLMssSSzLLUnkYWNMSc4pTeaE0N4Ocm2uIs4duakF-fGpxAdCGvNSSeE8fIzMDAwtTJ2OCCgASFDSS</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Pharmaceutical compositions comprising phenylaminopyrimidine derivative</title><source>esp@cenet</source><creator>Kali Satya Bhujanga Rao ADIBHATLA ; Durga Maheswari PARVATANENI ; Venkaiah Chowdary NANNAPANENI ; Mitrabhanu MOHANTY ; Venkata Satyanarayana APPADWEDULA</creator><creatorcontrib>Kali Satya Bhujanga Rao ADIBHATLA ; Durga Maheswari PARVATANENI ; Venkaiah Chowdary NANNAPANENI ; Mitrabhanu MOHANTY ; Venkata Satyanarayana APPADWEDULA</creatorcontrib><description>An oral pharmaceutical formulation containing an effective amount of NRC-AN-019 including its pharmaceutically acceptable salts and polymorphs thereof, by dispersing in a polymer system in a final state of subdivision to enhance oral bioavailability. It also relates to processes for the preparation of such compositions and using those compositions for the treatment of Chronic Myeloid Leukemia and other tumors such as head and neck cancer, prostate cancer and the like.</description><language>eng ; heb</language><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210930&DB=EPODOC&CC=IL&NR=260085B$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210930&DB=EPODOC&CC=IL&NR=260085B$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Kali Satya Bhujanga Rao ADIBHATLA</creatorcontrib><creatorcontrib>Durga Maheswari PARVATANENI</creatorcontrib><creatorcontrib>Venkaiah Chowdary NANNAPANENI</creatorcontrib><creatorcontrib>Mitrabhanu MOHANTY</creatorcontrib><creatorcontrib>Venkata Satyanarayana APPADWEDULA</creatorcontrib><title>Pharmaceutical compositions comprising phenylaminopyrimidine derivative</title><description>An oral pharmaceutical formulation containing an effective amount of NRC-AN-019 including its pharmaceutically acceptable salts and polymorphs thereof, by dispersing in a polymer system in a final state of subdivision to enhance oral bioavailability. It also relates to processes for the preparation of such compositions and using those compositions for the treatment of Chronic Myeloid Leukemia and other tumors such as head and neck cancer, prostate cancer and the like.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHAPyEgsyk1MTi0tyUxOzFFIzs8tyC_OLMnMzysGc4oyizPz0hUKMlLzKnMSczPz8gsqizJzM1My81IVUlKLMssSSzLLUnkYWNMSc4pTeaE0N4Ocm2uIs4duakF-fGpxAdCGvNSSeE8fIzMDAwtTJ2OCCgASFDSS</recordid><startdate>20210930</startdate><enddate>20210930</enddate><creator>Kali Satya Bhujanga Rao ADIBHATLA</creator><creator>Durga Maheswari PARVATANENI</creator><creator>Venkaiah Chowdary NANNAPANENI</creator><creator>Mitrabhanu MOHANTY</creator><creator>Venkata Satyanarayana APPADWEDULA</creator><scope>EVB</scope></search><sort><creationdate>20210930</creationdate><title>Pharmaceutical compositions comprising phenylaminopyrimidine derivative</title><author>Kali Satya Bhujanga Rao ADIBHATLA ; Durga Maheswari PARVATANENI ; Venkaiah Chowdary NANNAPANENI ; Mitrabhanu MOHANTY ; Venkata Satyanarayana APPADWEDULA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_IL260085B3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; heb</language><creationdate>2021</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Kali Satya Bhujanga Rao ADIBHATLA</creatorcontrib><creatorcontrib>Durga Maheswari PARVATANENI</creatorcontrib><creatorcontrib>Venkaiah Chowdary NANNAPANENI</creatorcontrib><creatorcontrib>Mitrabhanu MOHANTY</creatorcontrib><creatorcontrib>Venkata Satyanarayana APPADWEDULA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Kali Satya Bhujanga Rao ADIBHATLA</au><au>Durga Maheswari PARVATANENI</au><au>Venkaiah Chowdary NANNAPANENI</au><au>Mitrabhanu MOHANTY</au><au>Venkata Satyanarayana APPADWEDULA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Pharmaceutical compositions comprising phenylaminopyrimidine derivative</title><date>2021-09-30</date><risdate>2021</risdate><abstract>An oral pharmaceutical formulation containing an effective amount of NRC-AN-019 including its pharmaceutically acceptable salts and polymorphs thereof, by dispersing in a polymer system in a final state of subdivision to enhance oral bioavailability. It also relates to processes for the preparation of such compositions and using those compositions for the treatment of Chronic Myeloid Leukemia and other tumors such as head and neck cancer, prostate cancer and the like.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; heb |
| recordid | cdi_epo_espacenet_IL260085B |
| source | esp@cenet |
| title | Pharmaceutical compositions comprising phenylaminopyrimidine derivative |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T01%3A55%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Kali%20Satya%20Bhujanga%20Rao%20ADIBHATLA&rft.date=2021-09-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EIL260085B%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |